Nazartinib / EGF-816 CAS:1508250-71-2

Nazartinib / EGF-816 CAS:1508250-71-2
Product Details

Product Information

CAS NO.

1508250-71-2

 3.png

Product Name

Nazartinib

Synonyms

EGF816; NVS-816

Formula

C26H31ClN6O2

Molecular Weight

495.02

Spec / Purity

98%min

Supply Capacity


Details

Nazartinib (EGF816) is in phase II clinical trials by Novartis for treatment of non-small cell lung cancer  in combination with nivolumab.

If you are going to consult the information about nazartinib / egf-816 cas:1508250-71-2 from one of the leading Bioactive Molecules manufacturers and suppliers in China, It is always at your service.

Feedback